Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19.

MLA

Hollerbach, Anne, et al. “Pathogenic Lipid-Binding Antiphospholipid Antibodies Are Associated with Severity of COVID-19.” Journal of Thrombosis and Haemostasis : JTH, vol. 19, no. 9, Sept. 2021, pp. 2335–47. EBSCOhost, https://doi.org/10.1111/jth.15455.

APA

Hollerbach, A., Müller-Calleja, N., Pedrosa, D., Canisius, A., Sprinzl, M. F., Falter, T., Rossmann, H., Bodenstein, M., Werner, C., Sagoschen, I., Münzel, T., Schreiner, O., Sivanathan, V., Reuter, M., Niermann, J., Galle, P. R., Teyton, L., Ruf, W., & Lackner, K. J. (2021). Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19. Journal of Thrombosis and Haemostasis : JTH, 19(9), 2335–2347. https://doi.org/10.1111/jth.15455

Chicago

Hollerbach, Anne, Nadine Müller-Calleja, Denise Pedrosa, Antje Canisius, Martin F Sprinzl, Tanja Falter, Heidi Rossmann, et al. 2021. “Pathogenic Lipid-Binding Antiphospholipid Antibodies Are Associated with Severity of COVID-19.” Journal of Thrombosis and Haemostasis : JTH 19 (9): 2335–47. doi:10.1111/jth.15455.